NCT05085171RecruitingPhase 3
An Enhanced Package of Care to Reduce Reduce Mortality in Advanced HIV Disease
A Community-based Phase III, Cluster Randomized Trial of Point-of-care CD4 Testing and Enhanced Screening and Prophylaxis in Advanced HIV Disease
Source: ClinicalTrials.gov · Last updated 12 Jul 2022 · Not updated for over 12 months - ask the site whether it is still open
Brief summary (registry, in English)
A community-based Phase III, cluster randomized trial that seeks to determine the 24 week survival with retention in care of point of care CD4 testing with visitect and an enhanced package of screening and prophylaxis for opportunistic infections among patients with advanced HIV disease.
- Status (registry)
- Recruiting
- Phase (registry)
- Phase 3
- Study type
- Interventional
- Enrollment
- 2400 (estimated)
- First submitted
- 8 Oct 2021
- Start date
- 4 May 2022
- Primary completion date
- 1 Mar 2027
- Lead sponsor
- Makerere University
- Diseases
- HIV
- NCT number
- NCT05085171
What you commit to
- Study type: Interventional · Phase 3
- Planned participants: 2400
- From 4 May 2022 to the primary completion date, 1 Mar 2027
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Prior treatment
- Known virologic suppression (viral load \<1000 copies/mL) within prior 3 months
Other
- Cannot or unlikely to attend regular clinic visits
Who the study is looking for
- Age \>18 years
- CD4\<200 cells/µL
- Ability and willingness to give informed consent for the enhanced package of care arm.
Age in the registry: 18 years to - · Sex: All · Does not accept healthy volunteers
Sites (1)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| kisugu health center IV Coordinator of this site? Confirm its status | Kampala | Uganda | Recruiting |
This page is information, not medical advice. Discuss any trial with your doctor.